Advanced search
Publication Cover
Leukemia & Lymphoma Volume 64, 2023 - Issue 5
Submit an article Journal homepage
98
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Virtual care for multiple myeloma in the COVID-19 era: interrupted time series analysis of veterans health administration data

Christopher T. Sua Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA;b Rogel Cancer Center, Michigan Medicine, Ann Arbor, MI, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-2700-2650View further author information
ORCID Icon,
Jason C. Chena Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA;b Rogel Cancer Center, Michigan Medicine, Ann Arbor, MI, USAView further author information
&
Jeremy B. Sussmana Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA;c Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, MI, USAORCID Iconhttps://orcid.org/0000-0002-2158-3618View further author information
ORCID Icon
Pages 1035-1039 | Received 14 Sep 2022, Accepted 22 Jan 2023, Published online: 16 Mar 2023

References

  • Joseph NS, Kaufman JL, Dhodapkar MV, et al. Long-term follow-up results of lenalidomide, bortezomib, and dexamethasone induction therapy and risk-adapted maintenance approach in newly diagnosed multiple myeloma. J Clin Oncol. 2020;38(17):1928–1937.
  • Rajkumar SV. Multiple myeloma: 2020 update on diagnosis, risk-stratification and management. Am J Hematol. 2020;95(5):548–567.
  • Jethava YS, Fonseca R, Landgren O. Management of multiple myeloma during COVID-19 pandemic. Leuk Res Rep. 2020;14:100212.
  • Terpos E, Engelhardt M, Cook G, et al. Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN). Leukemia. 2020;34(8):2000–2011.
  • Mian HS, Fiala MA, Wildes TM. Burden of treatment among older adults with newly diagnosed multiple myeloma. Clin Lymphoma Myeloma Leuk. 2021;21(2):e152–e159.
  • Chari A, Samur MK, Martinez-Lopez J, et al. Clinical features associated with COVID-19 outcome in MM: first results from international myeloma society dataset. Blood. 2020;136(26):3033–3040.
  • Neparidze N, Wang R, Zeidan AM, et al. Changes in multiple myeloma treatment patterns during the early COVID-19 pandemic period. Leukemia. 2022;36(8):2136–2139.
  • Parikh RB, Takvorian SU, Vader D, et al. Impact of the COVID-19 pandemic on treatment patterns for patients with metastatic solid cancer in the United States. J Natl Cancer Inst. 2022;114(4):571–578.
  • Jiang CY, El-Kouri NT, Elliot D, Shields J, Caram MEV, Frankel TL, Ramnath N, Passero VA. Telehealth for Cancer Care in Veterans: Opportunities and Challenges Revealed by COVID. JCO Oncol Pract. 2021 Jan;17(1):22–29. doi: 10.1200/OP.20.00520. Epub 2020 Sep 24. PMID: 32970512.
  • Freeman CL, Mikhael J. COVID-19 and myeloma: what are the implications for now and in the future? Br J Haematol. 2020;190(2):173–178.
  • Jagannath S, Mikhael J, Nadeem O, et al. Digital health for patients with multiple myeloma: an unmet need. J Clin Oncol Clin Cancer Inform. 2021;5:1096–1105.
  • Schaffer AL, Dobbins TA, Pearson SA. Interrupted time series analysis using autoregressive integrated moving average (ARIMA) models: a guide for evaluating large-scale health interventions. BMC Med Res Methodol. 2021;21(1):58.
  • The ARIMA procdure. SAS Institute Inc. 2014. SAS/ETS® 13.2 User's Guide. Cary, NC: SAS Institute Inc.
  • ArunKumar KE, Kalaga DV, Sai Kumar CM, et al. Forecasting the dynamics of cumulative COVID-19 cases (confirmed, recovered and deaths) for top-16 countries using statistical machine learning models: auto-Regressive integrated moving average (ARIMA) and seasonal auto-regressive integrated moving average (SARIMA). Appl Soft Comput. 2021;103:107161.
  • Waxman AJ, Mink PJ, Devesa SS, et al. Racial disparities in incidence and outcome in multiple myeloma: a population-based study. Blood. 2010;116(25):5501–5506.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.